Results 201 to 210 of about 48,159 (229)

Survival and Prognostic Factors of 215 Post‐Transplant Lymphoproliferative Disorders After Solid Organ Transplantations in a Finnish Nationwide Population‐Based Study Over 30 Years

Hematological Oncology, Volume 44, Issue 2, March 2026.
ABSTRACT Post‐transplant lymphoproliferative disorder (PTLD) is a rare, dreaded complication of organ transplantation with major clinical challenges. We conducted a nationwide population‐based study of all solid organ transplant (SOT) recipients (n = 6555), both adults and children, over a 30‐year period in Finland.
Terhi K. Friman, Birgitta Salmela, Ilkka Helanterä, Fredrik Åberg, Timo Jahnukainen, Maija Halme, Samuli Vaittinen, Jyri Lommi, Markku O. Pentikäinen, Panu E. Kovanen, Sirpa Leppä, Riikka Räty   +11 more
wiley   +1 more source

Tacrolimus or Mycophenolate Mofetil for Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial.

JAMA Pediatr
Wang J, Liu F, Yan W, Zhou J, Zhang Y, Rong L, Jiang X, Zhao F, Zhu C, Wu X, Li X, Sun S, Wang J, Wang M, Yang Q, Xu H, Chen J, Liu C, Tian M, Feng S, Duan Q, Zhong X, Zhu Y, Li X, Fu H, Huang L, Ma D, Ding J, Ye Q, Mao J.   +29 more
europepmc   +1 more source

Long-term maintenance of mycophenolate mofetil in anti-NMDA receptor encephalitis (LEARN): a multicentre, open-label, blinded-endpoint, randomised controlled trial. [PDF]

J Neurol Neurosurg Psychiatry
Gong X, Liu Y, Ma Y, Yan B, An D, Guo Y, Liu X, Li X, Cai L, Deng X, Zhou D, Li JM, Hong Z.   +12 more
europepmc   +1 more source

Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages. [PDF]

Rheumatology (Oxford)
Morris EA, Parvizi R, Orzechowski NM, Whitfield ML, Pioli PA.   +4 more
europepmc   +1 more source

Safety of mycophenolate mofetil in systemic lupus erythematosus maintenance therapy: insights from the LUNA registry in a nationwide prospective cohort study. [PDF]

RMD Open
Matsuoka N, Yajima N, Inoue E, Sato S, Ogawa S, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Temmoku J, Fujita Y, Asano T, Fukita J, Sada KE, Ichinose K, Yoshimi R, Ohno S, Kajiyama H, Shimojima Y, Fujiwara M, Kida T, Miyawaki Y, Matsuo Y, Onishi T, Nishimura K, Migita K.   +25 more
europepmc   +1 more source

Mycophenolate Mofetil-Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis. [PDF]

J Vitreoretin Dis
Habib NB, Boss J.
europepmc   +1 more source

Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study. [PDF]

Rheumatol Immunol Res
Bai W, Peng L, Gui Y, Chen Y, Duan X, Li X, Zhang H, Huo Y, Xu J, Yang P, Wang Y, Wu C, Zhao J, Wang Q, Leng X, Tian X, Li M, Zeng X.   +17 more
europepmc   +1 more source

Successful Long-Term Treatment of Pediatric Relapsing Idiopathic Optic Neuritis with Mycophenolate Mofetil. [PDF]

Neurol Int
Fujino S, Akamine K, Noda E, Miyama S.
europepmc   +1 more source

Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study

American Journal of Hematology, Volume 101, Issue 3, Page 628-632, March 2026.
Zhenbin Wei, Rongrong Liu, Lingling Shi, Qiaochuan Li, Lianjin Liu, Baoshi Zheng, Chunjie Qin, Hong Chen, Guyun Wang, Meiqing Wu, Gaohui Yang, Ruolin Li, Zhaoping Gan, Qi Zhou, Jing Fan, Xuemei Zhou, Yinghua Chen, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai   +19 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mycophenolate-mofetil

Reactions Weekly, 2022
openaire   +2 more sources